| Literature DB >> 34245317 |
Päivi K Karjalainen1,2, Anna-Maija Tolppanen3, Nina K Mattsson4,5, Olga A E Wihersaari6,7, Jyrki T Jalkanen7,8, Kari Nieminen6,7.
Abstract
INTRODUCTION AND HYPOTHESIS: It is unclear how compartment of pelvic organ prolapse (POP) impacts overactive bladder (OAB) symptom severity or improvement after POP surgery. We hypothesized that anterior and apical prolapse are more strongly associated with OAB symptoms than posterior compartment prolapse.Entities:
Keywords: Overactive bladder; Pelvic organ prolapse; Pelvic organ prolapse surgery; Urgency urinary incontinence; Urinary frequency
Mesh:
Year: 2021 PMID: 34245317 PMCID: PMC8739293 DOI: 10.1007/s00192-021-04920-w
Source DB: PubMed Journal: Int Urogynecol J ISSN: 0937-3462 Impact factor: 1.932
Fig. 1Flowchart showing the selection of the study population. POP, pelvic organ prolapse; FINPOP, Finnish Pelvic Organ Prolapse Surgery Survey
Characteristics of the study population
| Characteristic | Study population | Data missing |
|---|---|---|
| Age (years), mean ± SD | 64.0 ± 10.5 | 2 (0.1) |
| BMI (kg/m²), mean ± SD | 26.9 ± 4.1 | 99 (3.4) |
| Parity, median (IQR) | 2 (1) | 47 (1.6) |
| Current smoker, | 255 (8.7) | 11 (0.4) |
| Diabetes, | 283 (9.6) | 0 |
| Prior hysterectomy, | 981 (33.4) | 0 |
| Prior POP surgery, | 740 (25.2) | 0 |
| Prior anti-incontinence surgery, | 170 (5.8) | 0 |
| POP-Q point Ba ≥ 0, | 1859 (65.5) | 96 (3.3) |
| POP-Q point C ≥ 0, | 1138 (40.6) | 130 (4.4) |
| POP-Q point Bp ≥ 0, | 1259 (44.5) | 105 (3.6) |
| PFDI-20 score, mean ± SD | 99.1 ± 49.9 | 5 (0.2) |
| OAB medication, | 97 (3.3) | 0 |
| Local or systemic estrogen therapy, | 2429 (82.9) | 4 (0.1) |
| Type of surgery, | 0 | |
| Native tissue repair | 2357 (80.4) | |
| Vaginal mesh | 362 (12.3) | |
| Abdominal mesh | 214 (7.3) |
SD, standard deviation; BMI, body mass index; IQR, interquartile range; POP, pelvic organ prolapse; POP-Q, Pelvic Organ Prolapse Quantification System; PFDI-20, Pelvic Floor Distress Inventory-20; OAB, overactive bladder
Prevalence of OAB symptoms at baseline and at follow-up
| Repair group | Symptom present | Urinary frequency | Urgency incontinence | Either symptom | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | 6 months | 24 months | Baseline | 6 months | 24 months | Baseline | 6 months | 24 months | ||
| 1890 (66.9) | 828 (33.7) | 910 (39.6) | 1759 (61.8) | 1186 (48.2) | 1158 (50.7) | 2346 (82.3) | 1422 (57.9) | 1451 (63.4) | ||
| 875 (31.0) | 204 (8.3) | 258 (11.2) | 744 (26.2) | 257 (10.4) | 326 (14.3) | 1135 (40.4) | 331 (13.6) | 423 (18.6) | ||
| 935 (33.1) | 1630 (66.3) | 1390 (60.4) | 1086 (38.2) | 1274 (51.8) | 1124 (49.3) | 504 (17.7) | 1035 (42.1) | 838 (36.6) | ||
| 1568 (69.8) | 650 (33.0) | 733 (39.8) | 1462 (64.6) | 958 (48.7) | 947 (51.9) | 1929 (85.1) | 1136 (57.8) | 1175 (64.1) | ||
| 735 (32.7) | 159 (8.1) | 198 (10.8) | 618 (27.3) | 202 (10.3) | 261 (14.3) | 945 (42.3) | 255 (13.1) | 333 (18.3) | ||
| 678 (30.2) | 1321 (67.0) | 1108 (60.2) | 801 (35.4) | 1011 (51.3) | 878 (48.1) | 338 (14.9) | 831 (42.2) | 657 (35.9) | ||
| 297 (54.6) | 165 (35.8) | 164 (38.1) | 273 (49.9) | 213 (45.7) | 197 (45.8) | 387 (70.6) | 268 (57.8) | 260 (60.5) | ||
| 129 (23.7) | 43 (9.3) | 57 (13.2) | 114 (20.8) | 51 (10.9) | 60 (14.0) | 175 (32.4) | 72 (15.7) | 84 (19.7) | ||
| 247 (45.4) | 296 (64.2) | 267 (61.9) | 274 (50.1) | 253 (54.3) | 233 (54.2) | 161 (29.4) | 196 (42.2) | 170 (39.5) | ||
Numbers presented as number (%) of data available at each time point
Association between overactive bladder symptoms and individual vaginal compartments at baseline
| Independent variable | Urinary frequency | Urgency urinary incontinence | ||||||
|---|---|---|---|---|---|---|---|---|
| ORa | 95% CI | aORb | 95% CI | ORa | 95% CI | aORb | 95% CI | |
| Ba (anterior wall prolapse) | ||||||||
| Bp (posterior wall prolapse) | 0.97 | 0.93–1.00 | 0.99 | 0.95–1.03 | ||||
| C (apical prolapse) | 1.04 | 1.00–1.05 | 1.01 | 0.98–1.03 | ||||
OR, odds ratio; CI, confidence interval; aOR, adjusted odds ratio
aGeneralized linear models, univariate analysis; bgeneralized linear models, multivariable model. Adjusted for prolapse in other compartments, age, BMI, parity, smoking, history of pelvic organ prolapse and anti-incontinence surgery
Fig. 2Association between the severity of overactive bladder symptoms and degree and compartment of prolapse at baseline. UUI, urgency urinary incontinence. Adjusted estimated marginal means with 95% confidence intervals for stages of individual compartments is shown. Stage 3 combines stages 3 and 4 for all compartments. For apical compartment, stage 1 combines stages 0 and 1
Prevalence of overactive bladder symptoms at baseline per stages of individual compartments
| Symptom | Compartment | Stage | Any degree of bothera | Bothersome symptomb | ||
|---|---|---|---|---|---|---|
| n with symptom/n total | % (95% CI) | n with symptom/n total | % (95% CI) | |||
| Frequency | Anterior | 0 | 264/444 | 59.5 (54.7–64.1) | 116/444 | 26.1 (22.1–30.5) |
| 1 | 184/298 | 61.7 (56.0–67.3) | 85/298 | 28.5 (23.5–34.0) | ||
| 2 | 785/1157 | 67.8 (65.1–70.5) | 349/1157 | 30.2 (27.5–32.9) | ||
| 3–4 | 602/831 | 72.4 (69.3–75.5) | 303/831 | 36.5 (33.2–39.8) | ||
| Posterior | 0 | 492/700 | 70.3 (66.7–73.7) | 231/700 | 33.0 (29.5–36.6) | |
| 1 | 312/434 | 71.9 (67.4–76.1) | 135/434 | 31.1 (26.8–35.7) | ||
| 2 | 759/1183 | 64.2 (61.4–66.9) | 350/1183 | 29.6 (27.0–32.3) | ||
| 3–4 | 259/404 | 64.1 (59.2–68.8) | 130/404 | 32.2 (27.6–37.0) | ||
| Apex | 0–1 | 858/1330 | 64.5 (61.9–67.1) | 379/1330 | 28.5 (26.1–31.0) | |
| 2 | 633/911 | 69.5 (66.4–72.5) | 300/911 | 32.9 (29.9–36.1) | ||
| 3–4 | 324/456 | 71.1 (66.7–75.2) | 162/456 | 35.5 (31.1–40.1) | ||
| UUI | Anterior | 0 | 224/449 | 49.9 (45.2–54.6) | 90/449 | 20.0 (16.4–24.1) |
| 1 | 169/298 | 56.7 (50.9–62.4) | 85/298 | 28.5 (23.5–34.0) | ||
| 2 | 769/1161 | 66.2 (63.4–69.0) | 313/1161 | 27.0 (25.8–32.1) | ||
| 3–4 | 554/842 | 65.8 (62.5–69.0) | 243/842 | 28.9 (25.8–32.1) | ||
| Posterior | 0 | 470/709 | 66.3 (62.7–69.8) | 212/709 | 29.9 (26.6–33.4) | |
| 1 | 299/438 | 68.3 (63.7–72.6) | 108/438 | 24.7 (20.7–29.0) | ||
| 2 | 697/1187 | 58.7 (55.9–61.5) | 299/1187 | 25.2 (22.7–27.8) | ||
| 3–4 | 233/408 | 57.1 (52.1–62.0) | 105/408 | 25.7 (21.6–30.3) | ||
| Apex | 0–1 | 826/1352 | 61.1 (58.4–63.7) | 343/1352 | 25.4 (23.1–27.8) | |
| 2 | 585/903 | 64.8 (61.6–67.9) | 261/903 | 28.9 (26.0–32.0) | ||
| 3–4 | 278/463 | 60.0 (55.4–64.5) | 114/463 | 24.6 (20.8–28.8) | ||
CI, confidence interval; UUI, urgency urinary incontinence
aAnswer ‘Yes’ in PFDI-20 questionnaire; bbothersome symptom defined as answers 3: moderately and 4: quite a bit in PFDI-20 questionnaire (Scale = 0–4)
Fig. 3Impact of surgery on overactive bladder symptoms. Impact of prolapse surgery on the overactive bladder symptom severity during the follow-up is shown. On the Y-axis, estimated marginal means (and their 95% confidence intervals) from linear generalized estimating equations multivariable model (scale 0–4, higher number indicating higher symptom bother: 0: symptom not present, 1: symptom present but not at all bothersome; 2: symptom somewhat bothersome; 3: symptom moderately bothersome; 4: symptom quite a bit bothersome). On the X-axis, follow-up points. On the left column, data stratified into two surgical groups. On the right, anterior/apical group stratified into three groups. The asterisk indicates P < 0.05, and NS indicates not significant (P > 0.05) for between-group comparison in an ordinal logistic generalized estimated equations model at different time points. P-values for within-group improvement and time*group interaction are reported for ordinal models. Between-group comparisons performed only for two groups (i.e., anterior/apical vs. posterior)
Fig. 4Change in symptom severity from baseline to 6 months for each overactive bladder symptom stratified by baseline symptom severity in the anterior/apical and the posterior groups. Each image depicts change in symptom severity from baseline to 6 month’s follow-up stratified by baseline symptom severity: baseline symptom severity on the left and 6 months’ symptom severity on the right. The scale of symptom severity: 4: symptom quite a bit bothersome; 3: symptom moderately bothersome; 2: symptom somewhat bothersome; 1: symptom present but not at all bothersome; 0: symptom not present. The thickness of the arrow is proportional to percentage